MBD4 and neoplasm: Taken together, the more severe clinical symptoms, reduced survival, and greater tumor burden in AOM/DSS treated Mbd4−/− versus WT mice suggest that the Mbd4 protein plays a role in suppressing inflammation-driven colon carcinogenesis.